These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20830400)

  • 21. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
    Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
    J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dichlorobis(2-phenylazopyridine)ruthenium(II) complexes: characterisation, spectroscopic and structural properties of four isomers.
    Velders AH; van der Schilden K; Hotze AC; Reedijk J; Kooijman H; Spek AL
    Dalton Trans; 2004 Feb; (3):448-55. PubMed ID: 15252553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
    Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2.
    Caspar R; Cordier C; Waern JB; Guyard-Duhayon C; Gruselle M; Le Floch P; Amouri H
    Inorg Chem; 2006 May; 45(10):4071-8. PubMed ID: 16676968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes.
    Bratsos I; Zangrando E; Serli B; Katsaros N; Alessio E
    Dalton Trans; 2005 Dec; (24):3881-5. PubMed ID: 16311642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ruthenium(II) [3 + 2 + 1] mixed ligand complexes: substituent effect on photolability, photooxidation of bases, photocytotoxicity and photonuclease activity.
    Sathyaraj G; Kiruthika M; Weyhermüller T; Nair BU
    Dalton Trans; 2012 Jul; 41(27):8460-71. PubMed ID: 22652837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diastereoselective synthesis of coordination compounds: a chiral tripodal ligand based on bipyridine units and its ruthenium(II) and iron(II) complexes.
    Hamann C; Von Zelewsky A; Neels A; Stoeckli-Evans H
    Dalton Trans; 2004 Feb; (3):402-6. PubMed ID: 15252546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of hexacoordinating benzimidazole containing ligand and hexakis(benzimidazole-ruthenium(II)) complex. Molecular structure of C6{CH2-(N-benzimidazole-RuCl2(p-cymene))}6.
    Požgan F; Toupet L; Dixneuf PH
    Dalton Trans; 2011 Jul; 40(25):6619-22. PubMed ID: 21589963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
    Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
    Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes.
    Murali M; Palaniandavar M
    Dalton Trans; 2006 Feb; (5):730-43. PubMed ID: 16429178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
    Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
    Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of ruthenium(II)-pyridylamine complexes with catechol pendants as metal binding sites.
    Kojima T; Hirasa N; Noguchi D; Ishizuka T; Miyazaki S; Shiota Y; Yoshizawa K; Fukuzumi S
    Inorg Chem; 2010 Apr; 49(8):3737-45. PubMed ID: 20329711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes.
    Thota S; Karki SS; Jayaveera KN; Balzarini J; De Clercq E
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):513-9. PubMed ID: 20128638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.